<DOC>
	<DOCNO>NCT02568280</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate postprandial glucose metabolism treatment faster-acting insulin aspart subject type 1 diabetes .</brief_summary>
	<brief_title>Investigating Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart Subjects With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Male female age 1864 year ( inclusive ) time sign informed consent Subjects diagnose ( clinically ) type 1 diabetes mellitus least 365 day prior day screen Body mass index 18.528.0 kg/m^2 ( inclusive ) Smoker ( define subject smoking least five cigarette equivalent per day ) able willing refrain smoking use nicotine gum transdermal nicotine patch inpatient period Subject donate blood plasma past month 500 mL within 3 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>